InMed Pharmaceuticals Inc. (INM) vs cbdMD, Inc. (YCBD)
- InMed Pharmaceuticals Inc. INM 1.32 −0.75%
- cbdMD, Inc. YCBD 0.35 −2.78%
InMed Pharmaceuticals Inc. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.3M against $4.0M — 1.8× the size. InMed Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; cbdMD, Inc. trades at 41.2×. InMed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 19.4% against 10.0%. InMed Pharmaceuticals Inc. has the higher net margin (0.00% vs −14.7%) and the higher return on invested capital (0.00% vs −29.8%). Across the 16 metrics below, cbdMD, Inc. leads on 10 and InMed Pharmaceuticals Inc. on 6.
Valuation
Profitability
| Metric | INM | YCBD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 26.27% | 57.68% | 53.94% |
| Operating margin | 0.00% | (13.87%) | 0.00% |
| Net margin | 0.00% | (14.71%) | 0.00% |
| Free cash flow margin | 0.00% | (11.51%) | 0.00% |
| Return on equity | (179.09%) | (43.01%) | (0.40%) |
| Return on assets | (139.63%) | (26.73%) | (3.32%) |
| Return on invested capital | 0.00% | (29.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack